TTK Healthcare Ltd 2022 AR2
The report details the financial and operational performance of TTK Healthcare Limited for the fiscal year 2021-2022, highlighting a 26% growth in revenue from continuing operations to Rs. 599.24 crores. It includes the Business Responsibility Report, which outlines the company's commitment to ethical governance, environmental sustainability, and employee well-being. Key highlights include the successful transfer of the Human Pharma Division to BSV Pharma Private Limited and a CSR expenditure of Rs. 65 lakhs dedicated to COVID-19 containment. The company also maintained certifications for environmental and occupational health standards across its manufacturing divisions.
Company: TTK Healthcare Ltd
Sector: Health Care
Country: India
Year: 2022
Type: AR2
Pages: 115
TTK Healthcare Ltd
Annual Report
The report details the financial and operational performance of TTK Healthcare Limited for the fiscal year 2021-2022, highlighting a 26% growth in revenue from continuing operations to Rs. 599.24 crores. It includes the Business Responsibility Report, which outlines the company's commitment to ethical governance, environmental sustainability, and employee well-being. Key highlights include the successful transfer of the Human Pharma Division to BSV Pharma Private Limited and a CSR expenditure of Rs. 65 lakhs dedicated to COVID-19 containment. The company also maintained certifications for environmental and occupational health standards across its manufacturing divisions.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Apr 1, 2021 - Mar 31, 2022
Fiscal Year
2022
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Employees